Chimerix Company Insiders

CMRX Stock  USD 8.47  0.01  0.12%   
Chimerix's insiders are aggressively selling. The analysis of the overall insider sentiment regarding Chimerix suggests that vertually all insiders are panicking. Chimerix employs about 72 people. The company is managed by 12 executives with a total tenure of roughly 22 years, averaging almost 1.0 years of service per executive, having 6.0 employees per reported executive.
Michael Alrutz  CEO
interim CEO, Senior Vice President General Counsel

Insider Sentiment 0

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2025-02-13Michelle LaspalutoDisposed 2260 @ 4.51View
2025-01-30Michelle LaspalutoDisposed 1015 @ 4.11View
2024-08-08Michael T AndrioleDisposed 1285 @ 0.83View
Monitoring Chimerix's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimerix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Chimerix Stock please use our How to Invest in Chimerix guide.

Chimerix's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chimerix's future performance. Based on our forecasts, it is anticipated that Chimerix will maintain a workforce of slightly above 70 employees by April 2025.
 
Yuan Drop
 
Covid

Chimerix Management Team Effectiveness

The company has return on total asset (ROA) of (0.3022) % which means that it has lost $0.3022 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4859) %, meaning that it created substantial loss on money invested by shareholders. Chimerix's management efficiency ratios could be used to measure how well Chimerix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.47 in 2025. Return On Capital Employed is likely to drop to -0.58 in 2025. At this time, Chimerix's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 363.5 K in 2025, whereas Total Assets are likely to drop slightly above 197 M in 2025.
Common Stock Shares Outstanding is likely to rise to about 107 M in 2025. Net Income Applicable To Common Shares is likely to rise to about 207.9 M in 2025

Chimerix Workforce Comparison

Chimerix is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 1,032. Chimerix holds roughly 72.0 in number of employees claiming about 7% of equities under Health Care industry.

Chimerix Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chimerix insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
1.5
12
8
 2,409,389 
 20,760 
2024-03-01
3.6667
11
3
 1,286,500 
 6,344 
2023-12-01
0.3846
5
13
 937,000 
 140,236 
2023-09-01
4.0
4
1
 213,000 
 3,610 
2023-03-01
5.5
11
2
 1,262,400 
 67,505 
2022-09-01
1.3333
4
3
 270,000 
 154,400 
2022-03-01
0.5
6
12
 1,699,800 
 730,535 
2021-06-01
3.6667
11
3
 320,250 
 6,534 
2021-03-01
2.0
6
3
 1,186,500 
 263,211 
2020-12-01
1.0
3
3
 15,584 
 18,354 
2020-09-01
0.5
5
10
 15,084 
 28,168 
2020-06-01
8.0
8
1
 645,000 
 0.00 
2020-03-01
1.4286
10
7
 1,349,270 
 271,392 
2019-09-01
0.5
1
2
 56,000 
 7,625 
2019-06-01
2.0
16
8
 2,057,000 
 25,740 
2019-03-01
0.7
7
10
 1,201,000 
 425,528 
2018-06-01
0.9231
12
13
 197,700 
 190,293 
2018-03-01
1.3333
8
6
 961,321 
 156,891 
2017-06-01
3.3333
10
3
 197,815 
 46,353 
2017-03-01
12.0
12
1
 491,258 
 45,750 
2016-12-01
0.2
1
5
 2,400 
 102,400 
2016-09-01
2.0
4
2
 35,144 
 15,000 
2016-06-01
10.5
21
2
 487,343 
 3,521 
2016-03-01
2.3333
14
6
 1,434,883 
 204,433 
2015-12-01
0.7
7
10
 143,408 
 11,534 
2015-09-01
0.7222
13
18
 50,953 
 98,203 
2015-06-01
1.5385
20
13
 106,853 
 19,920 
2015-03-01
1.1176
19
17
 505,724 
 45,524 
2014-12-01
1.2857
9
7
 60,905 
 28,962 
2014-09-01
0.3488
15
43
 766,182 
 4,094,879 
2014-06-01
2.8889
26
9
 412,331 
 73,716 
2014-03-01
0.6316
12
19
 552,900 
 4,091,818 
2013-12-01
0.7742
24
31
 268,946 
 4,414,687 
2013-06-01
2.5294
43
17
 31,369,565 
 1,472,655 

Chimerix Notable Stakeholders

A Chimerix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chimerix often face trade-offs trying to please all of them. Chimerix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chimerix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Michael MBAPresident CEOProfile
Michael Alrutzinterim CEO, Senior Vice President General CounselProfile
Dr JDGeneral VPProfile
MD MBAChief OfficerProfile
David CPAExec OfficerProfile
Joshua AllenChief ImipridonesProfile
Dr MBAChief OfficerProfile
Pablo MDHead AffairsProfile
Roy WareChief Manufacturing and Technology OfficerProfile
Thomas RigaChief OfficerProfile
Randall LanierChief Science OfficerProfile
Michelle LaSpalutoChief OfficerProfile

About Chimerix Management Performance

The success or failure of an entity such as Chimerix often depends on how effective the management is. Chimerix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chimerix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chimerix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.44)(0.47)
Return On Capital Employed(0.55)(0.58)
Return On Assets(0.44)(0.47)
Return On Equity(0.38)(0.40)
Please note, the imprecision that can be found in Chimerix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chimerix. Check Chimerix's Beneish M Score to see the likelihood of Chimerix's management manipulating its earnings.

Chimerix Workforce Analysis

Traditionally, organizations such as Chimerix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chimerix within its industry.

Chimerix Manpower Efficiency

Return on Chimerix Manpower

Revenue Per Employee4.5K
Revenue Per Executive27K
Net Loss Per Employee1.1M
Net Loss Per Executive6.8M
Working Capital Per Employee2.4M
Working Capital Per Executive14.2M

Additional Tools for Chimerix Stock Analysis

When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.